Pharmacologic Approaches to Smoking Cessation
Pharmacologic Approaches to Smoking Cessation
复制标题
DOI：
10.3928/01477447-20120525-07
复制
发表时间：
2012-06-01
期刊：
影响因子：
1.1
通讯作者：
Macaulay, Tracy
中科院分区：
文献类型：
--
作者：
Bailey, Abby M.;Macaulay, Tracy
吸烟者的发病率和死亡率更高。尽管存在已知的健康风险，但美国各地烟草制品的使用率仍然很高（约 19.3% 的成年人）。吸烟与心血管疾病、心血管危险因素（即高血压和动脉粥样硬化）、慢性阻塞性肺病、肺气肿和各种癌症的发病率较高有关。药物戒烟疗法已被用来促进戒烟。本文为临床医生提供了使用药物戒烟的说明，包括特殊人群的注意事项。
Cigarette smokers experience greater rates of morbidity and mortality. Despite the known health risks, use of tobacco products remains high throughout the United States (approximately 19.3% of adults). Tobacco use is associated with higher rates of cardiovascular illness, cardiovascular risk factors (ie, hypertension and atherosclerosis), chronic obstructive pulmonary disease, emphysema, and various types of cancer. Pharmacologic smoking cessation therapies have been used to facilitate abstinence from smoking. This article provides clinicians with instructions for the use of pharmacologic agents for smoking cessation, including considerations for special populations.